secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-05-29T21:01:10+00:00
Accession:  0001193125-26-248648
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics director Simantov resigns from Board effective May 23, 2026
--------------------------------------------------------------------------------

- Ms. Simantov resigned from the Board; no disagreement with company operations or policies.
- Separation Agreement waives all accrued and unpaid retainer fees from director compensation program.
- Her outstanding stock option awards and share ownership are unaffected; indemnification agreement continues for six years.
- Full text of Separation Agreement will be filed with the Company's Q2 2026 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526248648/0001193125-26-248648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526248648/d220128d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-248648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer